Aerosolization potential of cyclodextrins - Influence of the operating conditions

PDA Journal of Pharmaceutical Science and Technology

Volumn 60, Issue 5, 2006, Pages 314-322

  Le, V N P ^a   Leterme, P ^a   Gayot, A ^a   Flament, M P ^a  

^a UNIV LILLE   (France)

Author keywords

Cyclodextrins; Jet nebulization; Nebulization efficiency; Operating conditions

Indexed keywords

ANTIALLERGIC AGENT; ANTIINFLAMMATORY AGENT; BRONCHODILATING AGENT; CRYSMEB; CYCLODEXTRIN DERIVATIVE; GLUCOSE; HYDROXYPROPYLCYCLODEXTRIN; KLEPTOSE HP; METHYL BETA CYCLODEXTRIN; OLIGONUCLEOTIDE; PEPTIDE DERIVATIVE; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG; VACCINE;

AEROSOL; ANALYZER; ARTICLE; DENSITY; DEVICE; DRUG DISTRIBUTION; DRUG SOLUTION; LUNG; NEBULIZATION; NEBULIZER; PHYSICAL CHEMISTRY; PRESSURE; QUANTITATIVE ANALYSIS; SURFACE TENSION; TIME; TISSUE DISTRIBUTION; VISCOMETER; VISCOSITY;

AEROSOLS; CHEMISTRY, PHYSICAL; CYCLODEXTRINS; EXCIPIENTS; NEBULIZERS AND VAPORIZERS; PHARMACEUTICAL SOLUTIONS; SURFACE TENSION; ULTRASONICS; VISCOSITY;

EID: 33750380281     PISSN: 10797440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Agu, R. U.; Ugwoke, M. I.; Armand, M.; Kinget, R.; Verbeke, N. The lung as a route for systemic delivery of therapeutic proteins and peptides. Respiratory Research. 2001, 2, 198-209.
2. Evrard, B.; Bertholet, P.; Gueders, M.; Flament, M. P.; Piel, G.; Delattre, L.; Gayot, A.; Leterme P.; Foidart, J. M.; Cataldo, D. Cyclodextrins as a potential carrier in drug nebulization. J. Controlled Release 2004, 96, 403-410.
3. Kinnarinen, T.; Jarho, P.; Järvinen, K.; Järvinen, T. The in vitro pulmonary deposition of a budesonide/γ-cyclodextrin inclusion complex. Journal of Inclusion Phenomena and Macrocyclic Chemistry 2002, 44, 97-100.
4. Shao, Z.; Krishnamoorthy, R.; Mitra, A. K. Cyclodextrins as nasal absorption promoters of insulin: Mechanistic evaluations. Pharm. Res. 1992, 9 (9), 1157-1163.
5. Irie, T.; Uekama, K. Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J. Pharm. Sci. 1997, 86 (2), 147-162.
6. Vozone, C. M.; Cabral Marques, H. M. Complexation of budesonide in cyclodextrins and particle aerodynamic characterization of the complex solid form for dry powder inhalation. Journal of Inclusion Phenomena and Macrocyclic Chemistry 2002, 44, 111-115.
7. Moren, F. Dosage forms and formulation for drug administration to the respiratory tract. Drug Dev. Ind. Pharm. 1987, 13, 655-728.
8. Newman, S. P.; Pellow, P.G.D.; Clarke, S. W. Drop sizes from medical atomisers (nebulisers) for drug solutions with different viscosities and surface tensions. Atomisation Spray Technology 1987, 3, 1-11.
9. McCallion, O. N. M.; Taylor, K. M. G.; Thomas, M.; Taylor, A. J. The influence of surface tension on aerosols produced by medical nebulisers. Int. J. Pharm. 1996, 129, 123-136.
10. McCallion, O. N. M.; Patel, M. J. Viscosity effects on nebulisation of aqueous solutions. Int. J. Pharm. 1996, 130, 245-249.
11. Flament, M. P.; Leterme, P.; Gayot, A. Factors influencing nebulizing efficiency. Drug Dev. Ind. Pharm. 1995, 21 (20), 2263-2285.
12. 1 protease inhibitor. Int. J. Pharm. 1997, 148, 93-101.
13. Bertholet, P.; Gueders, M.; Georges, D.; Albert, A.; Barillaro, V.; Perly, B.; Cataldo, B.; Piel, G.; Delattre, L.; Evrard, B. The effect of cyclodextrins on the aqueous solubility of a new MMP inhibitor: phase solubility, H-NMR spectroscopy and molecular modelling studies, preparation and stability study of nebulizable solutions. Journal of Pharmacy and Pharmaceutical Sciences 2005, 8 (2), 164-175.
14. European Pharmacopoeia. 2.2.9. Viscosité-Méthode au tube capillaire. 2005, p. 30.
15. Aiache, J. M. Les aerosols médicamenteux. Il Farmaco 1973, 28, 243-266.
16. Davis, S. S. Physicochemical studies on aerosol solutions for drug delivery. I. Water-propylene glycol systems. Int. J. Pharm. 1978, 1, 71-83.
17. Davis, S. S.; Elson, G.; Whitmore, J. Physicochemical studies on aerosol solutions for drug delivery. II. Water-propylene glycol-Ethanol systems. Int. J. Pharm. 1978, 1, 85-93.
18. Mercer, T. T. Production and characterisation of aerosols. Archives of Internal Medicine 1973, 131 (1), 39-50.
19. United States Pharmacopeia 28. 601. Aerosols, nasal sprays, metered dose inhalers and dry powder inhalers-Particle size. 2005, p. 2364.